In the UK, the most advanced in its progress towards a usable vaccine is UK-based, London-listed AstraZeneca, which in partnership with University of Oxford has completed its Phase 2 trials and is moving on to Phase 3, looking to human testing in UK, Brazil and South Africa. NYSE-listed Pfizer moved into Phase 3 on July 27. Nasdaq-listed Moderna claims its Covid vaccine could be ready for use by the end of the year. Also in the US, Merck & Co is in late Phase 2 and is hoping to move to Phase 3 with its vaccine.
During a results briefing by Manulife US REIT’s manager on Aug 3, Jill Smith, CEO of the manager was upbeat about prospects for a vaccine against Covid-19, and hence expects an economic rebound in 2H2020. MUST owns nine properties in the US, of which two are in Atlanta, Georgia and three in California. Georgia and California, part of the so-called sun-belt in the US have experienced a surge in Covid cases.
Which companies are in the race for Covid vaccine that could offer the most hope for businesses in the US?
